Jonathan P. Foster - 26 Jan 2024 Form 3 Insider Report for Autonomix Medical, Inc. (AMIX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
26 Jan 2024, 19:43:55 UTC
Prior SEC filing
27 Dec 2023
Next SEC filing
18 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Trent Smith By Power of Attorney

Key filing fact

Jonathan P. Foster filed Form 3 for Autonomix Medical, Inc. (AMIX) on 26 Jan 2024.

Key facts

  • This page summarizes Jonathan P. Foster's Form 3 filing for Autonomix Medical, Inc. (AMIX).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 26 Jan 2024, 19:43.

Change

  • Previous filing in this sequence was filed on 27 Dec 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMIX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
725,000
Date
26 Jan 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMIX holding Derivative

Warrant (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
26 Jan 2024
Ownership
Direct
Underlying class
Common stock
Underlying amount
6,250
Exercise price
$1.00
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .